A panel that advises the CDC says the agency should adopt the recommendation because of a rare but dangerous blood-clotting disorder that’s been linked to the J&J vaccine.
A panel that advises the CDC says the agency should adopt the recommendation because of a rare but dangerous blood-clotting disorder that’s been linked to the J&J vaccine.